[1]
2022. EPIDEMIOLOGICAL INVESTIGATION AND CLINICAL MANAGEMENT FOR THE TREATMENT OF EPILEPSY. Journal of Pharmaceutical Negative Results. (Dec. 2022), 6432–6441.